These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2578277)

  • 21. Is there alpha-adrenergic blockade and/or serotonergic blockade during chronic ketanserin treatment?
    Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S120-2. PubMed ID: 2412031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketanserin, a new selective 5-HT2 receptor blocking agent, inhibits the antidiuretic effect of 5-hydroxytryptamine (5-HT) in Wistar rats.
    Cantalamessa F; de Caro G; Massi M; Micossi LG
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):302-7. PubMed ID: 6838287
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pronounced flush symptoms in carcinoid syndrome without liver metastases].
    Roth J; Raschka C; Hammar CH
    Leber Magen Darm; 1994 Nov; 24(6):259-61. PubMed ID: 7531269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Verapamil and diarrhoea in the carcinoid syndrome--clinical and experimental observations on serotonin release.
    Ahlman H; Nilsson O; Grönstad KO; Skolnik G; Tisell LE; Dahlström A
    Br J Cancer; 1986 Aug; 54(2):251-6. PubMed ID: 3741762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pentagastrin test as an indicator of a cure in surgically treated patients with advanced carcinoid disease.
    Ahlman H; Nilsson O; Dahlström A; Tisell LE
    J Surg Oncol; 1988 May; 38(1):52-6. PubMed ID: 2453757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peri-operative management of carcinoid syndrome using ketanserin.
    Houghton K; Carter JA
    Anaesthesia; 1986 Jun; 41(6):596-9. PubMed ID: 2942052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated concentrations of substance P and 5-HT in plasma in patients with carcinoid tumors.
    Emson PC; Gilbert RF; Martensson H; Nobin A
    Cancer; 1984 Aug; 54(4):715-8. PubMed ID: 6204735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of carcinoid levels of serotonin and substance P on hemodynamics.
    Zinner MJ; Yeo CJ; Jaffe BM
    Ann Surg; 1984 Feb; 199(2):197-204. PubMed ID: 6198979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
    Long RG; Peters JR; Bloom SR; Brown MR; Vale W; Rivier JE; Grahame-Smith DG
    Gut; 1981 Jul; 22(7):549-53. PubMed ID: 6114901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral serotonin2 receptor blockade does not inhibit 5-hydroxytryptophan-induced aldosterone stimulation.
    Shenker Y; Gross MD; Grekin RJ
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1201-4. PubMed ID: 2932460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin.
    Roberts LJ; Bloomgarden ZT; Marney SR; Rabin D; Oates JA
    Gastroenterology; 1983 Feb; 84(2):272-5. PubMed ID: 6184258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin and carcinoid tumors.
    Ahlman H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S79-85. PubMed ID: 2412066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction.
    Lau DH; Thompson CS; Bellringer JF; Thomas PJ; Mumtaz FH; Morgan RJ; Mikhailidis DP
    J Androl; 2006; 27(5):679-85. PubMed ID: 16728720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carcinoid and carcinoid syndrome].
    Sukhareva GV; Khomeriki SG
    Eksp Klin Gastroenterol; 2008; (3):110-9. PubMed ID: 19145891
    [No Abstract]   [Full Text] [Related]  

  • 35. Antagonism of the 5-HT-induced bronchoconstriction in the cat.
    Reiche R; Frey HH
    Arch Int Pharmacodyn Ther; 1983 May; 263(1):139-45. PubMed ID: 6615080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases.
    De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin, catecholamines, and spontaneous midgut carcinoid flush: plasma studies from flushing and nonflushing sites.
    Matuchansky C; Launay JM
    Gastroenterology; 1995 Mar; 108(3):743-51. PubMed ID: 7533112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudocarcinoid syndrome associated with hypogonadism and response to testosterone therapy.
    Shakir KM; Jasser MZ; Yoshihashi AK; Drake AJ; Eisold JF
    Mayo Clin Proc; 1996 Dec; 71(12):1145-9. PubMed ID: 8945484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
    van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP
    Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.